XWEL official logo XWEL
XWEL 1-star rating from Upturn Advisory
XWELL Inc. (XWEL) company logo

XWELL Inc. (XWEL)

XWELL Inc. (XWEL) 1-star rating from Upturn Advisory
$0.78
Last Close (24-hour delay)
upturn advisory logo
PASS
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

12/12/2025: XWEL (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

Upturn 1 star rating for performance

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

1 star rating from financial analysts

1 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $7

1 Year Target Price $7

Analysts Price Target For last 52 week
$7 Target price
52w Low $0.7
Current$0.78
52w High $1.85

Analysis of Past Performance

Type Stock
Historic Profit -55.24%
Avg. Invested days 30
Today’s Advisory PASS
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 12/12/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 4.48M USD
Price to earnings Ratio -
1Y Target Price 7
Price to earnings Ratio -
1Y Target Price 7
Volume (30-day avg) 1
Beta 1.23
52 Weeks Range 0.70 - 1.85
Updated Date 12/14/2025
52 Weeks Range 0.70 - 1.85
Updated Date 12/14/2025
Dividends yield (FY) -
Basic EPS (TTM) -3.34

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2025-11-17
When -
Estimate -
Actual -0.2557

Profitability

Profit Margin -51.85%
Operating Margin (TTM) -3.84%

Management Effectiveness

Return on Assets (TTM) -22.55%
Return on Equity (TTM) -158.99%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 10146728
Price to Sales(TTM) 0.15
Enterprise Value 10146728
Price to Sales(TTM) 0.15
Enterprise Value to Revenue 0.34
Enterprise Value to EBITDA 0.47
Shares Outstanding 5766703
Shares Floating 4314071
Shares Outstanding 5766703
Shares Floating 4314071
Percent Insiders 16.44
Percent Institutions 14.05

About XWELL Inc.

Exchange NASDAQ
Headquaters New York, NY, United States
IPO Launch date 2018-01-05
President, CEO & Director Mr. Ezra T. Ernst
Sector Healthcare
Industry Diagnostics & Research
Full time employees 246
Full time employees 246

XWELL, Inc. provides health and wellness services to travelers in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment provides traveler's spa services, including massage, and nail and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests to airport employees and traveling public at XpresCheck Wellness Centers in airports; operates the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels. The Napple Wax Center segment offers skincare and cometic products, as well as face and body waxing services. The Treat segment provides access to wellness services for travelers at on-site centers. The company offers its services through stores and kiosks, as well as online. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022. XWELL, Inc. is based in New York, New York.